CAS: 1207113-88-9
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | CCG-100602 REF: TM-T22062CAS: 1207113-88-9 | 99.86% | 38,00 €~442,00 € | Jue 16 May 24 |
 | CCG-100602 REF: 3D-HYB11388CAS: 1207113-88-9 | Min. 95% | A consultar | Jue 20 Jun 24 |
CCG-100602
CAS:1207113-88-9
CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells (IC50 :9.8 μM).
Fórmula:
C21H17ClF6N2O2
Pureza:
99.86%
Forma y color:
Solid
Peso molecular:
478.82
Ref: TM-T22062
| 5mg | 38,00 € | |
| 10mg | 56,00 € | |
| 25mg | 113,00 € | |
| 50mg | 185,00 € | |
| 100mg | 298,00 € | |
| 200mg | 442,00 € | |
| 1ml*10 (DMSO) | 52,00 € |
Entrega estimada en Estados Unidos, el Jueves 16 de Mayo de 2024
CCG-100602
CAS:1207113-88-9
CCG-100602 is a small molecule inhibitor that binds to the actin filament and prevents the …
Fórmula:
C21H17ClF6N2O2
Pureza:
Min. 95%
Peso molecular:
478.8 g/mol
Ref: 3D-HYB11388
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 20 de Junio de 2024
